Jenkins John Kenneth

DirectorProvention Bio, Inc. (PRVB) · full profile →Form 4 · filed Apr 27, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 27, 2023Disposed to issuer(D)23K0
Apr 27, 2023Disposed to issuer(D)33K0
Apr 27, 2023Disposed to issuer(D)129K0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-013914) within minutes of acceptance. Every field above traces to the original document. Verify it directly: